These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28266942)

  • 1. Personalized treatment in heart transplantation.
    Khush KK
    Curr Opin Organ Transplant; 2017 Jun; 22(3):215-220. PubMed ID: 28266942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant.
    Zhu A; Leto A; Shaked A; Keating B
    Gastroenterol Clin North Am; 2018 Jun; 47(2):281-296. PubMed ID: 29735024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of laboratory services for heart and lung transplantation in Australia.
    Schneider HG; Rutherford D; Kotsimbos T
    Clin Chim Acta; 2001 Nov; 313(1-2):221-9. PubMed ID: 11694263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term care of the heart transplant recipient.
    Kittleson MM; Kobashigawa JA
    Curr Opin Organ Transplant; 2014 Oct; 19(5):515-24. PubMed ID: 25160698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and beans: pharmacogenomics of renal transplant.
    Murray B; Hawes E; Lee RA; Watson R; Roederer MW
    Pharmacogenomics; 2013 May; 14(7):783-98. PubMed ID: 23651025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation.
    Maldonado AQ; West-Thielke P; Joyal K; Rogers C
    Pharmacotherapy; 2021 Jan; 41(1):132-143. PubMed ID: 33156560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive and Contemporary Review on Immunosuppression Therapy for Heart Transplantation.
    Goldraich LA; Leitão SAT; Scolari FL; Marcondes-Braga FG; Bonatto MG; Munyal D; Harrison J; Ribeiro RVP; Azeka E; Piardi D; Costanzo MR; Clausell N
    Curr Pharm Des; 2020; 26(28):3351-3384. PubMed ID: 32493185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results.
    Meiser B; Buchholz S; Kaczmarek I
    Curr Opin Organ Transplant; 2011 Oct; 16(5):522-8. PubMed ID: 21836511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine and Personalized Approach to Renal Transplantation.
    Dafoe DC; Tantisattamo E; Reddy U
    Semin Nephrol; 2018 Jul; 38(4):346-354. PubMed ID: 30082055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney.
    Sandovici M; Deelman LE; Benigni A; Henning RH
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1358-68. PubMed ID: 20688115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.
    Wiseman LR; Faulds D
    Drugs; 1999 Dec; 58(6):1029-42. PubMed ID: 10651389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for acute rejection in pediatric organ transplant recipients.
    Debray D; Furlan V; Baudouin V; Houyel L; Lacaille F; Chardot C
    Paediatr Drugs; 2003; 5(2):81-93. PubMed ID: 12529161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
    Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
    Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenomapping and outcomes after heart transplantation.
    Bakir M; Jackson NJ; Han SX; Bui A; Chang E; Liem DA; Ardehali A; Ardehali R; Baas AS; Press MC; Cruz D; Deng MC; DePasquale EC; Fonarow GC; Khuu T; Kwon MH; Kubak BM; Nsair A; Phung JL; Reed EF; Schaenman JM; Shemin RJ; Zhang QJ; Tseng CH; Cadeiras M
    J Heart Lung Transplant; 2018 Aug; 37(8):956-966. PubMed ID: 29802085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte markers and prediction of long-term renal allograft acceptance.
    Babel N; Reinke P; Volk HD
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.